TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through respiratory, cardiac and infection-detection models. Company data shared with Home Health Care News shows hospitalizations fell 14.9% year over year from April through August 2026; the figures are company-reported and do not establish that the platform alone caused the decline.
Phoenix-based Team Select Home Care says its CareSight AI platform now covers 100% of its patient census and that hospitalizations among its patients declined 14.9% year over year from April through August 2026. The provider shared the company’s five-month outcome comparison with Home Health Care News; the figures are not described as an independently evaluated study.
CareSight uses three machine-learning models focused on respiratory conditions, cardiac conditions and infection detection. Team Select says the platform draws on more than a decade of its patient records and monitors up to eight vital signs in real time, alongside nurse notes and reported changes in condition. It is intended to flag patterns that may signal a patient’s health is worsening so clinicians can respond.
The system was introduced in 2025, first for respiratory patients. Team Select President and CEO Fred Johnson told Home Health Care News that the respiratory model took three years to develop. The cardiac model followed and, he said, took six months; an infection model was developed in 90 days. The company says respiratory and cardiac models initially covered 65% of patients, before the infection model extended coverage to the full census.
Johnson said the reported outcome comparison covers April-August 2026 versus the same months in 2025. The 14.9% figure is a year-over-year reduction in hospitalization rates, according to Team Select data. It is distinct from the company’s historical rate figures: Johnson cited a seven-state Medicaid claims study commissioned by Team Select that put its monthly 30-day hospitalization rate before CareSight at 3% to 8%, compared with an industry average of 10% to 20% per month. Those baseline figures and the newer five-month result refer to different comparisons.
How Hospital Data Could Shape Payer Deals
The reported decline gives Team Select a performance measure it says it can use in discussions with health plans, as the home-care provider seeks to expand value-based contracts. In these arrangements, payment can be tied to outcomes or costs rather than relying only on standard fee-for-service rates. Johnson said the company wants to link potential additional revenue to reducing hospitalizations and total cost of care.
For patients with complex medical needs who receive care at home, avoiding a hospital stay may reduce disruption and support continued care outside the hospital. But the available information does not show how many admissions were avoided, whether the change affected specific patient groups, or what the platform cost to operate. Team Select’s results may be relevant to payers, but they do not by themselves establish that CareSight caused the decline or that similar results would occur at other providers.
AI health monitoring device for home care
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Respiratory Alerts to Full Coverage
Team Select serves medically complex children and seniors at home and operates in 16 states. Private equity firm Court Square Capital Partners invested in the company in 2023. The company says it committed $6 million to developing the predictive AI concept, built on its own patient data.
The platform’s development also involved adjusting how alerts work. Johnson said early versions generated too many false positives, including alerts for readings outside general parameters that were normal for an individual patient. Team Select added a patient-specific model that compares readings with a person’s historical baseline, the company said, with the goal of reducing alerts clinicians do not need to act on.
CareSight’s staged expansion reflects Team Select’s approach to selecting conditions: the company says it began with respiratory patients because of its high-acuity care experience, then used its data to identify cardiac conditions and infections as further areas linked to hospitalizations. The time needed to build later models fell, according to Johnson, as the company prepared its data and learned from earlier versions.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select Home Care president and CEO, speaking to Home Health Care News
patient vital signs monitor with real-time alerts
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Limits of the Five-Month Comparison
The reported 14.9% reduction comes from company data shared with Home Health Care News. The source material does not describe an independent audit, a control group, or a study design that could separate CareSight’s effect from other changes in staffing, patient mix, care practices or hospital use. It also does not provide the underlying patient counts, absolute hospitalization rates for April-August 2026, or results broken down by model or diagnosis.
It is also unclear how Team Select defines the hospitalization-rate measure in the five-month comparison, beyond identifying the periods compared. The older 3% to 8% company rate and 10% to 20% industry range were attributed to a separate, company-commissioned seven-state Medicaid claims study and should not be treated as the baseline for the 14.9% result. The company has not supplied outcome data on emergency department visits, total costs, or whether the decline persisted beyond August.
infection detection medical device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Diabetes Model and Payer Scorecards
Team Select is developing a fourth CareSight model focused on diabetes, Johnson told Home Health Care News. The source report does not give a launch date, the intended patient coverage, or expected outcome measures for that model.
The company is also redeveloping payer scorecards, which Johnson said would show health plans measures including patient Net Promoter Scores, hospitalization rates and emergency department visit ratios, with comparisons to industry averages. Team Select expects to use CareSight data in efforts to expand value-based contracting. Further results, including the model’s performance over a longer period and whether payers adopt contracts tied to its measures, have not yet been reported.
respiratory and cardiac health monitor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did Team Select report?
Team Select said its CareSight AI platform now covers 100% of its patient census and reported a 14.9% year-over-year drop in hospitalization rates from April through August 2026, based on company data.
What does CareSight monitor?
The platform uses respiratory, cardiac and infection-detection models. Team Select says it monitors up to eight vital signs alongside nurse notes and changes in a patient’s condition.
Does the reported decline prove the AI caused fewer hospitalizations?
No. The reported comparison is based on company data, and the source does not describe an independent evaluation or a control group that would establish the platform caused the reduction.
What is Team Select planning next?
Team Select is developing a fourth model focused on diabetes and redeveloping payer scorecards with measures such as hospitalization and emergency department visit ratios. The company has not announced a launch date for the diabetes model.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
